COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,180 Articles (22,713 medRxiv, 8,467 bioRxiv)

Most recent first Previous |  Page 1672: Articles 16711-16720  | Next

Freely accessible ready to use global infrastructure for SARS-CoV-2 monitoring
Maier, W., Bray, S., van den Beek, M., Bouvier, D., Coraor, N., Miladi, M., Singh, B., Rambla De Argila, J., Baker, D., Roach, N., Gladman, S., Coppens, F., Martin, D., Lonie, A., Gruning, B., Kosakovsky Pond, S., Nekrutenko, A.
10.1101/2021.03.25.437046 — Posted: 2021-03-25
Genomic surveillance and phylodynamic analyses reveal emergence of novel mutation and co-mutation patterns within SARS-CoV2 variants prevalent in India
Biswas, N., Mallick, P., Maity, S. K., Bhowmik, D., Mitra, A. G., Saha, S., Roy, A., Chakrabarti, P., Paul, S., Chakrabarti, S.
10.1101/2021.03.25.436930 — Posted: 2021-03-25
A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents
Do, T. N. D., Chatterjee, A. K., Gallay, P. A., Bobardt, M. D., Vangeel, L., De Jonghe, S., Neyts, J., Jochmans, D.
10.1101/2021.03.25.436907 — Posted: 2021-03-25
The Role of Testing Availability on Intentions to Isolate during the COVID-19 Pandemic - A Randomized Trial
Zhang, J. C., Christensen, K. L., Leuchter, R. K., Vangala, S., Han, M., Croymans, D. M.
10.1101/2021.03.22.21251380 — Posted: 2021-03-25
Computational prediction of the effect of amino acid changes on the binding affinity between SARS-CoV-2 spike protein and the human ACE2 receptor
Chen, C., Boorla, V. S., Banerjee, D., Chowdhury, R., Cavener, V. S., Nissly, R. H., Gontu, A., Boyle, N. R., Vandegrift, K., Nair, M. S., Kuchipudi, S. V., Maranas, C. D.
10.1101/2021.03.24.436885 — Posted: 2021-03-25
Efficacy of a Broadly Neutralizing SARS-CoV-2 Ferritin Nanoparticle Vaccine in Nonhuman Primates
Joyce, M. G., King, H. A. D., Elakhal Naouar, I., Ahmed, A., Peachman, K. K., Cincotta, C. M., Subra, C., Chen, R. E., Thomas, P. V., Chen, W.-H., Sankhala, R. S., Hajduczki, A., Martinez, E. J., Peterson, C. E., Chang, W. C., Choe, M., Smith, C., Lee, P. J., Headley, J. A., Taddese, M. G., Elyard, H. A., Cook, A., Anderson, A., McGuckin-Wuertz, K., Dong, M., Swafford, I., Case, J. B., Currier, J. R., Lal, K. G., O'Connell, R. J., Molnar, S., Nair, M. S., Dussupt, V., Daye, S. P., Zeng, X., Barkei, E. K., Staples, H. M., Alfson, K., Carrion, R., Krebs, S. J., Paquin-Proulx, D., Karasavva, N., Polonis, V. R., Jagodzinski, L. L., Amare, M. F., Vasan, S., Scott, P. T., Huang, Y., Ho, D. D., de Val, N., Diamond, M. S., Lewis, M. G., Rao, M., Matyas, G. R., Gromowski, G. D., Peel, S. A., Michael, N. L., Bolton, D. L., Modjarrad, K.
10.1101/2021.03.24.436523 — Posted: 2021-03-25
Demographic and clinical features associated with in-hospital mortality in Egyptian COVID-19 patients: A retrospective cohort study
Asem, N., Hassany, M., Taema, K., Masoud, H., Elassal, G., Kamal, E., Amin, W., Abdelbary, A., Abdel-Baki, A., Zaky, S., Abdalmohsen, A., Ibrahim, H., Elnady, M., Mohamed, A., Attia, E., Zaid, H.
10.1101/2021.03.22.21253577 — Posted: 2021-03-25
A Sanger-based approach for scaling up screening of SARS-CoV-2 variants of interest and concern
Bezerra, M. F., Machado, L. C., Carvalho, V., Docena, C., Brandao-Filho, S., Ayres, C. F. J., Paiva, M. H. S., Wallau, G. L.
10.1101/2021.03.20.21253956 — Posted: 2021-03-25
Building alternative consensus trees and supertrees using k-means and Robinson and Foulds distance
Tahiri, N., Fichet, B., Makarenkov, V.
10.1101/2021.03.24.436812 — Posted: 2021-03-25
A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variants
Schmitz, A. J., Turner, J. S., Liu, Z., Aziati, I. D., Chen, R. E., Joshi, A., Bricker, T. L., Darling, T. L., Adelsberg, D. C., Al Soussi, W. B., Case, J. B., Lei, T., Thapa, M., Amanat, F., O'Halloran, J. A., Shi, P.-Y., Presti, R. M., Krammer, F., Bajic, G., Whelan, S. P. J., Diamond, M. S., Boon, A. C. M., Ellebedy, A. H.
10.1101/2021.03.24.436864 — Posted: 2021-03-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).